Quell Therapeutics is pressing…
Quell Therapeutics is pressing pause on an engineered regulatory T-cell [...]
Quell Therapeutics is pressing pause on an engineered regulatory T-cell [...]
Bayer has linked asundexian to a 26% reduction in stroke [...]
Eikon Therapeutics is heading to the Nasdaq this morning with [...]
The Trump administration announced that the company, a pharmacy benefit [...]
The once high-flying Danish drugmaker has struggled to fend off [...]
As Eli Lilly awaits an FDA approval decision for its [...]
Novartis has nixed six early-stage pipeline programs, swapping in two [...]
Bristol Myers Squibb has signed Kasey Keller for a Breyanzi [...]
Stem cell therapy biotech PrimeGen US is taking the less-traveled [...]
Charles River Laboratories is continuing its run of layoffs by [...]